|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-7-24
|
|
pubmed:abstractText |
Ciclesonide is a new lung-activated inhaled corticosteroid (ICS) that has shown efficacy in previous placebo-controlled and comparative studies in patients with persistent asthma. It is important to compare new treatments with existing ICSs to obtain relative data concerning their efficacy and tolerability.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
906-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16860173-Administration, Inhalation,
pubmed-meshheading:16860173-Adolescent,
pubmed-meshheading:16860173-Adult,
pubmed-meshheading:16860173-Aged,
pubmed-meshheading:16860173-Asthma,
pubmed-meshheading:16860173-Budesonide,
pubmed-meshheading:16860173-Child,
pubmed-meshheading:16860173-Double-Blind Method,
pubmed-meshheading:16860173-Female,
pubmed-meshheading:16860173-Glucocorticoids,
pubmed-meshheading:16860173-Humans,
pubmed-meshheading:16860173-Hydrocortisone,
pubmed-meshheading:16860173-International Cooperation,
pubmed-meshheading:16860173-Male,
pubmed-meshheading:16860173-Middle Aged,
pubmed-meshheading:16860173-Pregnenediones,
pubmed-meshheading:16860173-Respiratory Function Tests
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
|
|
pubmed:affiliation |
National Heart and Lung Institute, Imperial College, London, United Kingdom. t.hansel@imperial.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
